Cellular senescence links muscle atrophy and posttraumatic osteoarthritis after ACL injury

Area of Science:

• Biomedical research
• Cellular biology
• Musculoskeletal research

Background:

• Traumatic knee injuries, such as anterior cruciate ligament (ACL) tears, often lead to posttraumatic osteoarthritis (PTOA) and persistent skeletal muscle weakness, causing chronic disability.
• Current treatments for traumatic knee injuries frequently fail to prevent long-term musculoskeletal dysfunction, indicating a critical need for novel therapeutic targets.
• Cellular senescence, a state of irreversible cell cycle arrest, has emerged as a potential contributor to age-related diseases and tissue dysfunction.

Purpose of the Study:

• To investigate the role of cellular senescence in the development of PTOA and associated muscle atrophy following traumatic knee injury.
• To identify specific cell types contributing to the senescent cell burden in the knee joint and surrounding muscle post-injury.
• To evaluate the therapeutic potential of senolytic agents in mitigating PTOA and muscle weakness in preclinical models and assess senescent cell burden in human patients.

Main Methods:

• Utilized a preclinical anterior cruciate ligament (ACL) transection model to induce PTOA and associated pathologies.
• Employed a novel SPiDER-senescence associated β-galactosidase staining technique for high-resolution, single-cell analysis of senescent cells in joint and muscle tissues.
• Administered the senolytic drug combination dasatinib and quercetin (D+Q) to assess its efficacy in clearing senescent cells and ameliorating injury-induced damage.
• Collected muscle tissue samples from human patients with ACL injury and PTOA for comparative analysis of senescent cell burden.

Main Results:

• Identified anti-inflammatory macrophages as a major source of senescent cells in both the knee joint cartilage and skeletal muscle following traumatic injury.
• Demonstrated that D+Q treatment significantly reduced muscle atrophy and cartilage degradation in the preclinical PTOA model.
• Observed a greater clearance of senescent cells in muscle tissue compared to cartilage following D+Q administration.
• Confirmed elevated senescent cell burden in the muscle of human patients who sustained ACL injury and have PTOA, which was resistant to standard care.

Conclusions:

• Cellular senescence, particularly driven by macrophages, plays a significant role in the pathophysiology of PTOA and associated muscle dysfunction after traumatic knee injury.
• Targeting cellular senescence with senolytic agents like D+Q presents a promising therapeutic strategy for improving functional recovery and mitigating joint and muscle damage post-injury.
• The persistence of senescent cells in human patients highlights the need for innovative treatments beyond the current standard of care to address PTOA and related muscle impairments.